ArticleFrontiers in medicine2026
Development and validation of machine learning nomograms for predicting mortality after cardiac valve surgery.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop and validate machine learning (ML) models for predicting mortality after heart valve surgery and compare their performance to the conventional EuroSCORE II, with the final goal of creating clinically accessible and easy-to-use nomograms. Methods: This multicenter, retrospective cohort study included 935 adult patients who underwent heart valve surgery. All-cause mortality at in-hospital, 30-day, and 365-day post-operative intervals were the primary outcomes. The Boruta algorithm was employed for feature selection. Five models, Logistic Regression, XGBoost, Random Forest, Extra Trees, and EuroSCORE II (as a benchmark), were developed on a 70% training set and validated on a 30% hold-out test set. Model performance was evaluated using the Area Under the Receiver Operating Characteristic Curve (ROC AUC), sensitivity, and specificity. The best-performing model for each endpoint was converted into a nomogram. Results: Machine learning models demonstrated strong discriminative performance across all endpoints. For in-hospital mortality, the Extra Trees model achieved the highest discrimination (ROC-AUC 0.858). For 30-day mortality, Logistic Regression showed the best performance (ROC-AUC 0.800), substantially exceeding EuroSCORE II (ROC-AUC 0.610). For 365-day mortality, predictive performance was comparable across models, with EuroSCORE II demonstrating similar discrimination (ROC-AUC 0.787). Key predictive features consistently included age and biomarkers reflecting cardiac stress, renal function, and hepatic function. The derived nomograms exhibited good discrimination and calibration in both internal and external validation cohorts. Conclusion: Machine learning models, particularly ensemble approaches, improved short-term mortality prediction following valve surgery compared with EuroSCORE II. The developed nomograms provide a practical and interpretable tool for individualized perioperative risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.